Ligand Pharmaceuticals | 営業経費



Operating Expenses 変化する 日付
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 163.91M 1.71M 2024-12
Baxter International USD 3.19B 644M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Insmed USD 334.86M 28M 2024-12
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.66B 1.67B 2025-03
Pacira USD 162.55M 145.55M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Veracyte USD 114.46M 10.61M 2024-12



Ligand Pharmaceuticals 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.